Table 2.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||
---|---|---|---|---|---|---|---|---|---|---|
1 Distress | – | |||||||||
2 SES | −.055 | – | ||||||||
3 Age | −.198† | −.166† | – | |||||||
4 GSRS | .484† | −.117* | −.133† | – | ||||||
5 Experiential Avoidance | .734† | −.117* | −.214† | .358† | – | |||||
6 COVID Fear | .307† | −.074 | −.03 | .249† | .263† | – | ||||
7 Isolation | .525† | .008 | −.069 | .322† | .441† | .421† | – | |||
8 Immunomodulators | −.011 | .001 | −.104** | .008 | .01 | .05 | .011 | – | ||
9 Female Gender | −.145† | .021 | .022 | −.108** | −.124† | −.081** | −.167† | -.041 | – | |
10 Job loss during COVID | .046 | −.066 | −.016 | .029 | .013 | .1** | .074* | .027 | −.085* | |
11 Living with others | .089* | −.024 | −.149† | .139† | .052 | .053 | .02 | −.006 | −.023 | -.01 |
*p < .05, ** p < .01
† p < .001